{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:04:03Z","timestamp":1777626243470,"version":"3.51.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"11","funder":[{"name":"Tisch Cancer Institute at Mount Sinai"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Human papillomavirus (HPV)+\u2005oropharynx cancer (OPC) has a more favorable prognosis than HPV-negative disease, but the impact of specific HPV genotype and phylogenic clade on patient outcomes is not well understood and has profound implications for treatment de-intensification.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The objective of this single-institution cohort study was to investigate the association of HPV genotype (16 vs high-risk non-16) and clade (A9 vs A7) with OPC outcomes. The primary endpoints were overall survival (OS) and event-free survival (EFS) in patients with M0 disease treated with curative intent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The cohort included 598 patients (87% HPV16, 98% A9). Compared to those with HPV16 OPC, individuals with non-HPV16 OPC had a higher age, comorbidity index, and proportion of non-whites, HIV+ patients, T4 tumors, and stage IV disease (AJCC 7th edition). Non-HPV16 genotype was associated with worse OS in univariate (HR\u2005=\u20052.17, 95% CI, 1.24-3.80, P\u2005=\u2005.0066), but not in multivariate analysis (HRadj\u2005=\u20050.84, 95% CI, 0.43-1.62, P\u2005=\u2005.5921). A7 clade was associated with worse OS in univariate (HR\u2005=\u20054.42, 95% CI, 1.60-12.30, P\u2005=\u2005.0041), but not in multivariate analysis (HRadj\u2005=\u20052.39, 95% CI, 0.57-9.99, P\u2005=\u2005.2325). Neither HPV genotype (HR\u2005=\u20051.60, 95% CI, 0.99-2.60, P\u2005=\u2005.0566) nor phylogenic clade (HR\u2005=\u20052.47, 95% CI, 0.91-6.72, P\u2005=\u2005.0761) was associated with EFS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Non-HPV16 genotype and A7 clade were associated with worse OS and trended toward worse EFS in univariate analyses. The survival differences were more pronounced by phylogenic clade than by HPV16 status, suggesting that the former may be a more useful classification for future studies. However, neither HPV16 status nor phylogenic clade was prognostic when adjusting for patient and tumor covariates, raising the question as to whether possible differences in outcomes are related to distinct clinical profiles rather than inherent viral properties.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/oncolo\/oyae202","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T18:29:37Z","timestamp":1723573777000},"page":"966-977","source":"Crossref","is-referenced-by-count":3,"title":["Association of human papillomavirus genotype and\u00a0phylogenic clade with oropharyngeal cancer outcomes"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1128-0226","authenticated-orcid":false,"given":"Michael T","family":"Wotman","sequence":"first","affiliation":[{"name":"Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX 77030 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Ivic-Pavlicic","sequence":"additional","affiliation":[{"name":"Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H","family":"Westra","sequence":"additional","affiliation":[{"name":"Department of Pathology, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Gold","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Rutgers New Jersey Medical School , Newark, NJ 07103 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"D\u2019Andrea","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M","family":"Genden","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Misiukiewicz","sequence":"additional","affiliation":[{"name":"Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A","family":"Roof","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5734-4806","authenticated-orcid":false,"given":"Emanuela","family":"Taioli","sequence":"additional","affiliation":[{"name":"Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["United States"]},{"name":"Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall","family":"Posner","sequence":"additional","affiliation":[{"name":"Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"issue":"9","key":"2024110817125494200_CIT0001","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a causal association between human papillomavirus and a subset of head and neck cancers","volume":"92","author":"Gillison","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"32","key":"2024110817125494200_CIT0002","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"2024110817125494200_CIT0003","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.seminoncol.2004.09.011","article-title":"Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity","volume":"31","author":"Gillison","year":"2004","journal-title":"Semin Oncol"},{"issue":"1","key":"2024110817125494200_CIT0004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"2024110817125494200_CIT0005","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/annonc\/mdr006","article-title":"Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial","volume":"22","author":"Posner","year":"2011","journal-title":"Ann Oncol"},{"issue":"2","key":"2024110817125494200_CIT0006","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3322\/caac.21758","article-title":"Consensuses, controversies, and future directions in treatment deintensification for human &#x2028;papillomavirus-associated oropharyngeal cancer","volume":"73","author":"Kang","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"40","key":"2024110817125494200_CIT0007","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1038\/s41388-023-02819-y","article-title":"Clinical, morphologic and molecular heterogeneity of HPV-associated oropharyngeal cancer","volume":"42","author":"Lim","year":"2023","journal-title":"Oncogene"},{"issue":"1-2","key":"2024110817125494200_CIT0008","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.virol.2013.07.018","article-title":"Human papillomavirus genome variants","volume":"445","author":"Burk","year":"2013","journal-title":"Virology"},{"issue":"6","key":"2024110817125494200_CIT0009","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAP.0b013e3181f895c1","article-title":"Human papillomavirus detection in head and neck squamous cell carcinomas","volume":"17","author":"Snow","year":"2010","journal-title":"Adv Anat Pathol"},{"issue":"18","key":"2024110817125494200_CIT0010","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.ejca.2015.09.005","article-title":"Human papillomavirus genotype and oropharynx cancer survival in the United States of America","volume":"51","author":"Goodman","year":"2015","journal-title":"Eur J Cancer"},{"issue":"6","key":"2024110817125494200_CIT0011","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jamaoncol.2015.6587","article-title":"Human papillomavirus genotype association with survival in head and neck squamous cell carcinoma","volume":"2","author":"Bratman","year":"2016","journal-title":"JAMA Oncol"},{"issue":"7","key":"2024110817125494200_CIT0012","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/ijc.33893","article-title":"Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer","volume":"150","author":"Garset-Zamani","year":"2022","journal-title":"Int J Cancer"},{"key":"2024110817125494200_CIT0013","doi-asserted-by":"crossref","first-page":"106644","DOI":"10.1016\/j.oraloncology.2023.106644","article-title":"Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: a systematic review and meta-&#x2028;analysis","volume":"148","author":"Shenker","year":"2024","journal-title":"Oral Oncol"},{"issue":"7","key":"2024110817125494200_CIT0014","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1080\/00016489.2021.1927173","article-title":"The impact of HPV genotypes on survival in HPV-positive oropharyngeal squamous cell carcinomas: a systematic review","volume":"141","author":"Skovvang","year":"2021","journal-title":"Acta Otolaryngol"},{"issue":"9","key":"2024110817125494200_CIT0015","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/ijc.32038","article-title":"Genetic variations in human papillomavirus and cervical cancer outcomes","volume":"144","author":"Rader","year":"2019","journal-title":"Int J Cancer"},{"issue":"4","key":"2024110817125494200_CIT0016","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ijrobp.2009.09.021","article-title":"Clinical effect of human papillomavirus genotypes in patients with cervical cancer undergoing primary radiotherapy","volume":"78","author":"Wang","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2024110817125494200_CIT0017","first-page":"459","article-title":"Human papillomavirus genotype affects metastatic rate following radiotherapy in patients with uterine cervical cancer","volume":"15","author":"Okonogi","year":"2018","journal-title":"Oncol Lett"},{"issue":"1","key":"2024110817125494200_CIT0018","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cncy.22076","article-title":"Molecular testing of residual cytology samples: Rethink, reclaim, repurpose","volume":"127","author":"Roy-Chowdhuri","year":"2019","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"2024110817125494200_CIT0019","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s12105-021-01308-6","article-title":"Comparing outcomes for patients with Human Papillomavirus (HPV) type 16 versus other high-risk HPV types in oropharyngeal squamous cell carcinoma","volume":"15","author":"Shenker","year":"2021","journal-title":"Head Neck Pathol"},{"issue":"4","key":"2024110817125494200_CIT0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/cncr.29086","article-title":"Prevalence and prognostic value of human papillomavirus genotypes in tonsillar squamous cell carcinoma: a Korean multicenter study","volume":"121","author":"No","year":"2015","journal-title":"Cancer"},{"issue":"9","key":"2024110817125494200_CIT0021","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/hed.24442","article-title":"Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes","volume":"38","author":"Varier","year":"2016","journal-title":"Head Neck"},{"key":"2024110817125494200_CIT0022","doi-asserted-by":"crossref","first-page":"104522","DOI":"10.1016\/j.oraloncology.2019.104522","article-title":"Distinct biomarker and behavioral profiles of human papillomavirus-related oropharynx cancer patients by age","volume":"101","author":"Fakhry","year":"2020","journal-title":"Oral Oncol"},{"issue":"6","key":"2024110817125494200_CIT0023","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.oraloncology.2013.09.008","article-title":"The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas","volume":"50","author":"Benson","year":"2014","journal-title":"Oral Oncol"},{"key":"2024110817125494200_CIT0024","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.oraloncology.2016.08.019","article-title":"Prognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma","volume":"61","author":"Mazul","year":"2016","journal-title":"Oral Oncol"},{"key":"2024110817125494200_CIT0025","doi-asserted-by":"crossref","first-page":"104488","DOI":"10.1016\/j.oraloncology.2019.104488","article-title":"HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes","volume":"100","author":"Chatfield-Reed","year":"2020","journal-title":"Oral Oncol"},{"key":"2024110817125494200_CIT0026","doi-asserted-by":"crossref","first-page":"105109","DOI":"10.1016\/j.oraloncology.2020.105109","article-title":"Human papillomavirus genotype distribution in head and neck cancer: Informing developing strategies for cancer prevention, diagnosis, treatment and surveillance","volume":"113","author":"Mashiana","year":"2021","journal-title":"Oral Oncol"},{"issue":"1","key":"2024110817125494200_CIT0027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1916-0216-42-9","article-title":"Does HPV type affect outcome in oropharyngeal cancer","volume":"42","author":"Nichols","year":"2013","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"1","key":"2024110817125494200_CIT0028","first-page":"6672373","article-title":"Does HPV subtype predict outcomes in head and neck cancers","volume":"2021","author":"Ziai","year":"2021","journal-title":"Int J Otolaryngol"},{"issue":"6","key":"2024110817125494200_CIT0029","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3904\/kjim.2017.397","article-title":"Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment","volume":"34","author":"Yoo","year":"2019","journal-title":"Korean J Intern Med"},{"key":"2024110817125494200_CIT0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.oraloncology.2019.06.021","article-title":"Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trial","volume":"95","author":"Misiukiewicz","year":"2019","journal-title":"Oral Oncol"},{"issue":"9807","key":"2024110817125494200_CIT0031","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"2024110817125494200_CIT0032","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1158\/1541-7786.MCR-21-0443","article-title":"Comprehensive viral genotyping reveals prognostic viral phylogenetic groups in HPV16-&#x2028;associated squamous cell carcinoma of the oropharynx","volume":"20","author":"Schrank","year":"2022","journal-title":"Mol &#x2028;Cancer Res"},{"issue":"3","key":"2024110817125494200_CIT0033","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(23)00013-X","article-title":"Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis","volume":"24","author":"Mehanna","year":"2023","journal-title":"Lancet Oncol"},{"key":"2024110817125494200_CIT0034","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.oraloncology.2019.02.006","article-title":"Real-time PCR HPV genotyping in fine needle aspirations of metastatic head and neck squamous cell carcinoma: exposing the limitations of conventional p16 immunostaining","volume":"90","author":"El-Salem","year":"2019","journal-title":"Oral Oncol"},{"issue":"1","key":"2024110817125494200_CIT0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/oncolo\/oyab001","article-title":"Comparison of the seventh and eighth edition of American Joint Committee on Cancer (AJCC) staging for selected and nonselected oropharyngeal squamous cell carcinomas","volume":"27","author":"Vijayvargiya","year":"2022","journal-title":"Oncologist"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/29\/11\/966\/60541980\/oyae202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/29\/11\/966\/60541980\/oyae202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T17:13:34Z","timestamp":1731086014000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/29\/11\/966\/7732932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,8,13]]},"published-print":{"date-parts":[[2024,11,4]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyae202","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,8,13]]}}}